Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Resmed Inc (NY: RMD )

220.90 +5.05 (+2.34%)
Streaming Delayed Price Updated: 3:16 PM EDT, May 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Resmed Inc

< Previous 1 2 3 4 5 6 7 8 Next >
AT&T To Rally Around 44%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Recap: ResMed Q2 Earnings
Via Benzinga
Earnings Scheduled For January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
3 Stocks to Buy to Benefit From the Booming Sleep Industry
It’s not easy to find sleep stocks to buy despite the fact the industry is booming these days from society's lack of rest and relaxation. 
Via InvestorPlace
ResMed's Earnings: A Preview
Via Benzinga
Why NYSE:RMD provides a good dividend, while having solid fundamentals.
Exploring RESMED INC (NYSE:RMD)'s dividend characteristics. 
Via Chartmill
FDA Identifies ResMed's Recall Of Certain Ventilator Device Masks With Magnets As Most Serious
ResMed (NYSE: RMD) recalls certain respiratory masks with magnets due to potential interference with medical devices. FDA Class I recall. 
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
If You Invested $100 In This Stock 15 Years Ago, You Would Have $900 Today
Via Benzinga
Demystifying ResMed: Insights From 5 Analyst Reviews
Via Benzinga
Uncovering Dividend Opportunities with NYSE:RMD.
Why RESMED INC (NYSE:RMD) qualifies as a good dividend investing stock. 
Via Chartmill
$1000 Invested In ResMed 15 Years Ago Would Be Worth This Much Today
Via Benzinga
(RMD) - Analyzing ResMed's Short Interest
Via Benzinga
If You Invested $1000 In This Stock 20 Years Ago, You Would Have $17,000 Today
Via Benzinga
Top Picks 2024: ResMed
ResMed is the market leader in continuous positive airway pressure machines. ResMed has enjoyed a steadily growing market throughout its history, and investors have often paid sky-high valuations for... 
Via Talk Markets
Why NYSE:RMD qualifies as a good dividend investing stock.
Is RESMED INC (NYSE:RMD) a Good Fit for Dividend Investing? 
Via Chartmill
Senator's Bearish Tesla Bet Under Scrutiny As He Buys Put Options Ahead Of Elon Musk-Led Company's Q3 Results That Set Stock Slide In Motion
Sen. Tommy Tuberville bought 3 tranches of put options to sell Tesla shares at $190 a day ahead of Q3 results that set in motion a stock slump. 
Via Benzinga
Why the dividend investor may take a look at NYSE:RMD.
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
2 Monster Stocks to Buy Without Any Hesitation
Down 33% and 44%, these two stocks look too good to pass up today. 
Via The Motley Fool
Is NYSE:RMD a Good Fit for Dividend Investing?
Analyzing RESMED INC (NYSE:RMD)'s Dividend Potential. 
Via Chartmill
Expert Ratings for ResMed
Via Benzinga
How Sleep Device Player ResMed Is Gaining Philips' Market Share In Flow Generator Market - Analysts Weigh In
Needham analyst Mike Matson reiterated a Buy rating on ResMed Inc. (NYSE: RMD)  
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
3 Stocks to Buy From the ‘Buy the Dip’ ETF
It’s a lot harder than it looks to buy the dip. Using artificial intelligence to do this makes these three stocks a buy. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exxon Mobil To Rally Around 23%? Here Are 10 Other Analyst Forecasts For Thursday
Cantor Fitzgerald cut Hyliion Holdings Corp. (NYSE: HYLN) price target from $2 to $1. Cantor Fitzgerald analyst Andres Sheppard downgraded the stock from Neutral to Underweight. Hyliion shares fell... 
Via Benzinga
Earnings Scheduled For October 26, 2023
Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnings at $2.57 per share on revenue of $49.83 billion. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2023
Via Benzinga
3 Top Growth Stock Picks Trading at a Massive Bargain
These growth stock picks are trading at bargain prices and are well-positioned to rebound and deliver substantial gains in the coming months. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 169 companies set new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.